Research & Studies: CBD for Parkinson's Disease
Here is a list of research and studies on CBD and it’s potential use for treating Parkinson’s Disease.
CBD for Parkinson’s Disease:
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial.
- Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: importance of antioxidant and cannabinoid receptor-independent properties.
- Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series.
- Prospects for cannabinoid therapies in basal ganglia disorders.
- Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s disease.
- Cannabidiol for the treatment of psychosis in Parkinson’s disease.
- Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson’s disease.
- Neurological Aspects of Medical Use of Cannabidiol.
- Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease.
- Therapeutic potential of cannabinoids in CNS disease.
IMPORTANT: Most of these studies involve cannabinoid molecules, experimental animals, test tubes, and sometimes human cell-lined studies. It’s important to understand that the Endocannabinoid System exists in all mammals including dogs, cats, rabbits, horses, and humans. CBD affects us in the same way that it affects our pets.